Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy

March 04, 2025
ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025. The stock price at the time of the signal was $67.99, and it reached $77.25 by the target date.

The success of this forecast highlights the accuracy of QuantWave's predictive analytics in the financial markets. The achievement of the price target for ASTRAZENECA PLC demonstrates the platform's ability to provide valuable insights and opportunities for profitable trades.

Several factors may have contributed to the stock's movement in line with the forecast. Positive developments in the company's pipeline, regulatory approvals, or overall market sentiment towards the pharmaceutical sector could have played a role in driving the price higher within the predicted timeframe.

QuantWave offers automated forecasting for a wide range of stocks, presenting users with opportunities to capitalize on market trends and make informed investment decisions. For investors looking to enhance their understanding of QuantWave's forecasting system, QuantSchool provides a professional investment framework that reveals key principles for achieving consistent income.

Overall, the successful forecast for ASTRAZENECA PLC reinforces QuantWave's position as a reliable source of financial analysis and underscores the platform's potential to deliver profitable investment opportunities for users.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....

AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....

AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....

AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....

AZNFebruary 19, 2025AstraZeneca PLC: Cutting-Edge Innovations and Rising Dividends  ~2 min.

AstraZeneca PLC (AZN) has emerged as one of the most promising foreign dividend stocks in recent years, attracting attention from analysts and investors alike....

AZNDecember 9, 2024Is AstraZeneca PLC AZN the Most Profitable Pharmaceutical Stock Right Now?  ~2 min.

AstraZeneca PLC (AZN) is emerging as one of the most profitable pharmaceutical stocks in the market....

AZNDecember 26, 2024AstraZeneca Faces Investigation in China; Shares Plummet  ~2 min.

AstraZeneca PLC (AZN) shares dropped significantly today following reports of a probe by the People's Republic of China (PRC) into alleged fraud and corruption within the company....

AZNAugust 2, 2024ASTRAZENECA PLC Hits Price Target Forecast with 26.05% Profit, Confirms QuantWave Accuracy  ~2 min.

QuantWave's forecast for ASTRAZENECA PLC proved to be highly accurate as the stock reached the predicted price target on August 2, 2024....

AZNJanuary 1, 2025New breakthrough in medical research announced by AstraZeneca PLC AZN  ~2 min.

Leading pharmaceutical company AstraZeneca PLC AZN has made a groundbreaking discovery in the field of medical research....

AZNFebruary 14, 2025AstraZeneca PLC AZN Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges  ~2 min.

During the recent Q4 2024 earnings call, AstraZeneca PLC (AZN) reported impressive financial results amidst various challenges faced by the pharmaceutical company....